Inst Diagnosti (INDISA) — Capital Reinvestment Ratio

Latest as of June 2023: 0.20x

Inst Diagnosti (INDISA) has a Capital Reinvestment Ratio of 0.20x as of June 2023, meaning it reinvests 0% of its operating cash flow (CL$8.87 Billion) in capital expenditures (CL$1.74 Billion). See Inst Diagnosti balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.20x
Capex / Operating Cash Flow

Operating Cash Flow

CL$8.87 Billion
CLP

Capital Expenditures

CL$1.74 Billion
CLP

Data as of

Jun 2023
Most recent filing

Inst Diagnosti Capital Reinvestment Ratio (2014–2021)

This chart tracks Inst Diagnosti's Capital Reinvestment Ratio across 8 annual periods. Check Inst Diagnosti (INDISA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Inst Diagnosti (2014–2021)

Year-by-year Capital Reinvestment Ratio for Inst Diagnosti from 2014 to 2021. For live market cap and broader valuation context, see INDISA market cap overview.

Year Reinvestment Ratio Operating CF (CLP) Capital Expenditures YoY Change
2021 2.12x CL$14.83 Billion CL$31.45 Billion ▲ +146.2%
2020 0.86x CL$14.46 Billion CL$12.45 Billion ▲ +23.4%
2019 0.70x CL$10.66 Billion CL$7.44 Billion ▲ +118.0%
2018 0.32x CL$14.75 Billion CL$4.72 Billion ▼ -44.8%
2017 0.58x CL$14.89 Billion CL$8.63 Billion ▼ -31.0%
2016 0.84x CL$11.57 Billion CL$9.73 Billion ▲ +2.9%
2015 0.82x CL$15.05 Billion CL$12.30 Billion ▲ +84.0%
2014 0.44x CL$13.58 Billion CL$6.03 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow